CN113633832A - Method for manufacturing ureteral stent anti-crusting coating based on anionic resin - Google Patents
Method for manufacturing ureteral stent anti-crusting coating based on anionic resin Download PDFInfo
- Publication number
- CN113633832A CN113633832A CN202110883588.XA CN202110883588A CN113633832A CN 113633832 A CN113633832 A CN 113633832A CN 202110883588 A CN202110883588 A CN 202110883588A CN 113633832 A CN113633832 A CN 113633832A
- Authority
- CN
- China
- Prior art keywords
- coating
- ureteral stent
- crusting
- resin
- slowly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
Abstract
The invention discloses a method for preparing an anti-incrustation coating of a ureteral stent based on anionic resin, which is characterized in that the anionic resin which is an anti-incrustation effective component is prepared into a coating solution to form a coating on a coating substrate in a solution dipping, spraying or roller coating mode, and the coating is combined on the ureteral stent which is taken as the coating substrate in a covalent bond mode after drying and curing. According to the scheme of the invention, the stable coating based on the anionic resin is coated on the surface of the ureteral stent, so that the aims of reducing the crusting quantity and relieving the difficulty in stent removal are fulfilled. The coating method has the advantages of low cost, simple process, suitability for large-scale production, good biocompatibility of the main components and high clinical application value.
Description
Technical Field
The invention relates to the technical field of medical treatment, in particular to a method for manufacturing a ureteral stent anti-crusting coating based on anionic resin.
Background
The ureter bracket is a medical appliance used for auxiliary treatment of urolithiasis, and is used for relieving benign or malignant obstruction of the ureter, promoting recovery of the ureter and treating urine extravasation. The ureteral stent is usually made of high polymer or metal, and after being implanted into a patient, the upper end of the ureteral stent is started and fixed on a renal pelvis and extends into a bladder along the ureter, so that the ureteral stent plays a role in expanding the ureter. During the time the ureteral stent is in place, it is often the case that significant urinary salt deposits (encrustation) and urethral stones are produced at the surface due to prolonged contact with urine. The crusting on the surface of the ureteral stent can obviously increase the resistance in the removal process, reduce the success rate of the removal operation and simultaneously increase the infection risk of the ureter/urethra of a patient after the operation.
In order to reduce the amount of incrustation generated on the surface of the ureteral stent during indwelling, the coating of the functional coating on the surface of the ureter is the most common strategy. Some instruments have coated the ureteral surface with a hydrophilic hydrogel coating, such as polyvinylpyrrolidone (PVP) or Polyacrylamide (PAM), which claims to reduce the adherence of urine salts and microorganisms to the stent surface, but in practice hydrogel coatings are susceptible to rapid erosion and exfoliation in the presence of urine with very high ionic strength and a drastic change in composition. The damaged hydrogel coating is more beneficial to the accumulation of microorganisms and urine salt due to uneven surface, and the generation of crusting is promoted.
Another strategy for preventing ureteral stent incrustation is to load phenolic antibiotics (such as triclosan and the like) or buffer substances (such as phosphate buffer and the like) into the coating, so that the phenolic antibiotics or buffer substances are slowly released in the using process, and the functions of killing microorganisms in urine and preventing urine salt deposition are achieved. However, on one hand, the abuse of antibiotics can aggravate the prevalence of drug-resistant bacteria such as antibiotic-resistant staphylococcus aureus (MRSA) in hospital environment, and on the other hand, the urine environment with extremely high salt concentration and large pH fluctuation can completely make the release rate of effective substances of the slow-release/buffer coatings uncontrollable, so that the ureteral stent coatings gradually lose the original effects in the later stage of long-term retention.
In addition, an apparatus manufacturer forms a diamond-like inert coating on the surface of the ureteral stent, the coating can greatly reduce the bonding of hydrophilic substances, mineral salts, microorganisms and the like in urine to the surface of the stent due to covalent bonds or intermolecular forces, the coating has good corrosion resistance, can be kept in the urine for a long time without change, and has good biocompatibility. However, the technology has the disadvantages of high cost, expensive processing machine, complex process and difficult popularization.
Disclosure of Invention
In view of the above, the technical problem to be solved by the present invention is to provide a method for manufacturing an anion resin-based ureteral stent anti-crusting coating, which is used for coating a stable anion resin-based coating on the surface of a ureteral stent, so as to achieve the purposes of reducing the number of crusts and reducing the difficulty in stent removal. The coating method has the advantages of low cost, simple process, suitability for large-scale production, good biocompatibility of the main components and high clinical application value.
Therefore, the invention discloses the following technical scheme:
a method for manufacturing an anionic resin-based ureteral stent anti-crusting coating comprises the following steps:
(1) putting the anion resin into pure water, and violently stirring by a magnetic stirrer to disperse the anion resin into dispersion liquid;
(2) adding an activating agent into the dispersion liquid, and continuously stirring to form an activated emulsion;
(3) then slowly adding the waterborne polyurethane coating into the activated emulsion, and violently stirring to fully mix the waterborne polyurethane coating and the activated emulsion to form a coating solution;
(4) taking a ureteral stent as a coating substrate, forming a coating on the coating substrate by using a coating solution in a solution dipping, spraying or roller coating mode, and then drying and curing to form an anti-crusting coating on the surface of the coating substrate; the anionic polymer as the main effective component of the anti-crusting coating is bonded on the ureteral stent as the coating substrate in a covalent bond mode.
Preferably, the anionic resin is a resin with a carbon-carbon bond as a main chain containing sulfonic acid side chain groups.
More preferably, the anionic resin is a polyethylene sulfonate resin.
Preferably, the molecular weight of the anion resin is between 120K and 2500K, the functional group of the Lewis acid is deprotonated to become sodium salt, potassium salt and the like, and the components are insoluble in water.
Preferably, the backbone conformation of the anionic resin is a random conformation.
Preferably, the anti-crusting coating thickness is between 0.1 and 0.5mm
Preferably, the activator is an aziridine activator.
Preferably, step (4) forms a coating on the coated substrate by solution dipping, specifically: and slowly immersing the ureteral stent made of polyether type thermoplastic polyurethane into the coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s.
As a preferred embodiment of the invention, the method for manufacturing the anti-crusting coating of the ureteral stent based on the anionic resin comprises the following steps:
(1) taking 4.0g of random sodium polyvinyl sulfonate high polymer with the molecular weight of 200K, putting the random sodium polyvinyl sulfonate high polymer into 12mL of pure water, and violently stirring the mixture by using a magnetic stirrer to disperse the mixture to form dispersion liquid;
(2) adding 0.6g of aziridine activating agent into the dispersion, and continuously stirring for 20min to form activated emulsion;
(3) then, 20g of waterborne polyurethane coating is slowly added into the activated emulsion, and is slowly added into the activated emulsion containing the sodium polyvinyl sulfonate high polymer, and the mixture is stirred vigorously for 30min to be fully mixed
(4) Taking the ureteral stent made of polyether type thermoplastic polyurethane, slowly immersing the ureteral stent into a coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s; and (3) putting the soaked ureteral stent into a 65-DEG C drying oven to dry for 2.5h to obtain a finished ureteral stent product with an anti-crusting coating.
For the ureteral stent finished product with the anti-crusting coating, whether the anionic resin is successfully grafted or not can be verified through the dyeing of a 1% cresol red solution on the coating on the surface of the ureteral stent or a photoelectron spectroscopy test.
Compared with the prior art, the scheme disclosed by the invention at least comprises the following beneficial effects:
1. the anionic high polymer serving as the main anti-crusting active ingredient of the coating has better stability in urine, and is not easy to corrode or fall off in the urine environment compared with a common hydrophilic coating (such as polyvinylpyrrolidone);
2. the anionic polymer serving as the main anti-crusting effective component of the coating can play a certain local buffering role due to the fact that the anionic polymer contains more Lewis acid groups, and can reduce urine salt deposition caused by severe pH change of urine;
3. the anionic polymer as the main anti-crusting effective component of the coating can definitely reduce the deposition of urinary salts such as calcium oxalate and the like on the surface of the substrate in-vitro tests;
4. anionic polymers (such as calcium polyvinyl sulfonate) have been used in humans as drugs to reduce blood potassium. Most of the high polymers do not participate in the metabolic process of human bodies, do not cause heat sources and immune reactions, and have good biocompatibility;
5. the coating technology has the advantages of low raw material cost and simple process, and is suitable for large-scale production and popularization.
Detailed Description
The present invention will be described in further detail with reference to examples. The following examples are intended to illustrate the invention only and are not intended to limit the scope of the invention. The method of carrying out the process without specifying the conditions in the examples is usually carried out in a conventional manner.
The invention discloses a method for manufacturing a ureteral stent anti-crusting coating based on anionic resin, which comprises the following steps:
(1) putting the anion resin into pure water, and violently stirring by a magnetic stirrer to disperse the anion resin into dispersion liquid;
(2) adding an activating agent into the dispersion liquid, and continuously stirring to form an activated emulsion;
(3) then slowly adding the waterborne polyurethane coating into the activated emulsion, and violently stirring to fully mix the waterborne polyurethane coating and the activated emulsion to form a coating solution;
(4) taking a ureteral stent as a coating substrate, forming a coating on the coating substrate by using a coating solution in a solution dipping, spraying or roller coating mode, and then drying and curing to form an anti-crusting coating on the surface of the coating substrate; the anionic polymer as the main effective component of the anti-crusting coating is bonded on the ureteral stent as the coating substrate in a covalent bond mode.
Among them, the anion resin is preferably a resin having a carbon-carbon bond as a main chain and having a sulfonic acid side chain group. More preferably, the anionic resin is a polyethylene sulfonate resin.
The molecular weight of the anionic resin is 120-2500K, the functional group of the Lewis acid is deprotonated to become sodium salt, potassium salt and the like, and the components are insoluble in water. The backbone conformation of the anionic resin is a random conformation. In order to achieve a good anti-crusting effect as quickly as possible, the anti-crusting coating thickness is between 0.1 and 0.5mm
As a preferred embodiment of the invention, the method for manufacturing the anti-crusting coating of the ureteral stent based on the anionic resin comprises the following steps:
(1) taking 4.0g of random sodium polyvinyl sulfonate high polymer with the molecular weight of 200K, putting the random sodium polyvinyl sulfonate high polymer into 12mL of pure water, and violently stirring the mixture by using a magnetic stirrer to disperse the mixture to form dispersion liquid;
(2) adding 0.6g of aziridine activating agent into the dispersion, and continuously stirring for 20min to form activated emulsion;
(3) then, 20g of waterborne polyurethane coating is slowly added into the activated emulsion, and is slowly added into the activated emulsion containing the sodium polyvinyl sulfonate high polymer, and the mixture is stirred vigorously for 30min to be fully mixed
(4) Taking the ureteral stent made of polyether type thermoplastic polyurethane, slowly immersing the ureteral stent into a coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s; and (3) putting the soaked ureteral stent into a 65-DEG C drying oven to dry for 2.5h to obtain a finished ureteral stent product with an anti-crusting coating.
For the ureteral stent finished product with the anti-crusting coating, whether the anionic resin is successfully grafted or not can be verified through the dyeing of a 1% cresol red solution on the coating on the surface of the ureteral stent or a photoelectron spectroscopy test.
Compared with the prior art, the scheme disclosed by the invention at least comprises the following beneficial effects:
1. the anionic high polymer serving as the main anti-crusting active ingredient of the coating has better stability in urine, and is not easy to corrode or fall off in the urine environment compared with a common hydrophilic coating (such as polyvinylpyrrolidone);
2. the anionic polymer serving as the main anti-crusting effective component of the coating can play a certain local buffering role due to the fact that the anionic polymer contains more Lewis acid groups, and can reduce urine salt deposition caused by severe pH change of urine;
3. the anionic polymer as the main anti-crusting effective component of the coating can definitely reduce the deposition of urinary salts such as calcium oxalate and the like on the surface of the substrate in-vitro tests;
4. anionic polymers (such as calcium polyvinyl sulfonate) have been used in humans as drugs to reduce blood potassium. Most of the high polymers do not participate in the metabolic process of human bodies, do not cause heat sources and immune reactions, and have good biocompatibility;
5. the coating technology has the advantages of low raw material cost and simple process, and is suitable for large-scale production and popularization.
The present invention will be described in further detail with reference to examples.
Example 1: 4.0g of a random sodium polyvinylsulfonate high polymer having a molecular weight of 200K was taken and put into 12mL of pure water, and vigorously stirred with a magnetic stirrer to disperse the polymer. To the dispersion was added 0.6g of aziridine activator (DSM)TMCX-100 crosslinking agent) and stirring is continued for 20 min. Then 20g of aqueous polyurethane coating (DSM)TMNEOREZ-R9621) is slowly added into the emulsion containing the sodium polyvinyl sulfonate high polymer, and stirred vigorously for 30min to mix thoroughly. Taking a ureteral stent of polyether type thermoplastic polyurethane with the specification of 6Fr, slowly immersing the ureteral stent into the coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s. The soaked ureter stent is put into a 65 ℃ oven to be dried for 2.5h,and obtaining the finished product of the ureteral stent with the anti-crusting coating.
Example 2: the coating on the surface of the ureteral stent can be used for verifying whether the anionic resin is successfully grafted or not by dyeing with a 1% cresol red solution or testing through photoelectron spectroscopy. From the detection results, successful grafting can be realized by adopting the ureteral stent finished product obtained by the scheme in example 1. And the clinical use effect is also excellent.
The above disclosure is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the scope of the present invention, therefore, the present invention is not limited by the appended claims.
Claims (9)
1. A method for manufacturing an anti-incrustation coating of a ureteral stent based on an anionic resin is characterized by comprising the following steps:
(1) putting the anion resin into pure water, and violently stirring by a magnetic stirrer to disperse the anion resin into dispersion liquid;
(2) adding an activating agent into the dispersion liquid, and continuously stirring to form an activated emulsion;
(3) then slowly adding the waterborne polyurethane coating into the activated emulsion, and violently stirring to fully mix the waterborne polyurethane coating and the activated emulsion to form a coating solution;
(4) taking a ureteral stent as a coating substrate, forming a coating on the coating substrate by using a coating solution in a solution dipping, spraying or roller coating mode, and then drying and curing to form an anti-crusting coating on the surface of the coating substrate; the anionic polymer as the main effective component of the anti-crusting coating is bonded on the ureteral stent as the coating substrate in a covalent bond mode.
2. The method of claim 1, wherein: the anion resin is resin which contains sulfonic side chain groups and takes carbon-carbon bonds as a main chain.
3. The method of claim 2, wherein: the anion resin is polyethylene sulfonate resin.
4. The method of claim 3, wherein: the molecular weight of the anion resin is between 120K and 2500K, the functional group of the Lewis acid is deprotonated to become sodium salt, potassium salt and the like, and the components are insoluble in water.
5. The method of claim 2, wherein: the backbone conformation of the anionic resin is a random conformation.
6. The method of claim 1, wherein: the anti-crusting coating thickness is between 0.1 and 0.5 mm.
7. The method of claim 1, wherein: the activator is an aziridine activator.
8. The method of claim 1, wherein: and (4) forming a coating on the coating substrate in a solution dipping mode, which specifically comprises the following steps: and slowly immersing the ureteral stent made of polyether type thermoplastic polyurethane into the coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s.
9. The method of claim 1, comprising the steps of:
(1) taking 4.0g of random sodium polyvinyl sulfonate high polymer with the molecular weight of 200K, putting the random sodium polyvinyl sulfonate high polymer into 12mL of pure water, and violently stirring the mixture by using a magnetic stirrer to disperse the mixture to form dispersion liquid;
(2) adding 0.6g of aziridine activating agent into the dispersion, and continuously stirring for 20min to form activated emulsion;
(3) then, 20g of waterborne polyurethane coating is slowly added into the activated emulsion, and is slowly added into the activated emulsion containing the sodium polyvinyl sulfonate high polymer, and the mixture is stirred vigorously for 30min to be fully mixed
(4) Taking the ureteral stent made of polyether type thermoplastic polyurethane, slowly immersing the ureteral stent into a coating solution, standing for 30s after the ureteral stent is completely immersed, and slowly withdrawing the ureteral stent from the liquid surface at the speed of 1 cm/s; and (3) putting the soaked ureteral stent into a 65-DEG C drying oven to dry for 2.5h to obtain a finished ureteral stent product with an anti-crusting coating.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110883588.XA CN113633832A (en) | 2021-08-03 | 2021-08-03 | Method for manufacturing ureteral stent anti-crusting coating based on anionic resin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110883588.XA CN113633832A (en) | 2021-08-03 | 2021-08-03 | Method for manufacturing ureteral stent anti-crusting coating based on anionic resin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113633832A true CN113633832A (en) | 2021-11-12 |
Family
ID=78419599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110883588.XA Pending CN113633832A (en) | 2021-08-03 | 2021-08-03 | Method for manufacturing ureteral stent anti-crusting coating based on anionic resin |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113633832A (en) |
Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050208100A1 (en) * | 2004-03-19 | 2005-09-22 | Jan Weber | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
| US20050266038A1 (en) * | 2004-05-27 | 2005-12-01 | Thierry Glauser | Antifouling heparin coatings |
| CN1736504A (en) * | 2005-07-25 | 2006-02-22 | 南通大学 | Nanometer compound antibacterial rubber urinary catheter and manufacturing method thereof |
| CN101812265A (en) * | 2009-02-24 | 2010-08-25 | 赛诺医疗科学技术有限公司 | Hydrophilic coat solution applied to surface of medicinal instrument and preparation method thereof |
| CN103301551A (en) * | 2013-06-09 | 2013-09-18 | 广州维力医疗器械股份有限公司 | Wetting component for hydrophilic urinary catheter |
| CN103948971A (en) * | 2014-03-20 | 2014-07-30 | 北京迪玛克医药科技有限公司 | Intervention catheter surface treatment method and intervention catheter |
| US20140271774A1 (en) * | 2013-03-14 | 2014-09-18 | W. L, Gore & Associates, Inc, | Coating For A Surface |
| CN105597217A (en) * | 2016-02-29 | 2016-05-25 | 浙江曙光科技有限公司 | PVC ultra-smooth hydrophilic catheter and preparation method thereof |
| CN105963798A (en) * | 2015-10-15 | 2016-09-28 | 淮海工学院 | Water-based lubricant, preparation method and application thereof |
| CN105983138A (en) * | 2015-02-11 | 2016-10-05 | 北京迪玛克医药科技有限公司 | Hydrophilic lubricating polyurethane medical interventional catheter and manufacturing method thereof |
| CN109045367A (en) * | 2018-07-13 | 2018-12-21 | 北京化工大学 | A kind of preparation method of hydrophilic coating and products thereof on medical catheter seal wire surface |
| CN110373069A (en) * | 2018-04-12 | 2019-10-25 | 中国科学院化学研究所 | A kind of hydrogel coating and the preparation method and application thereof |
-
2021
- 2021-08-03 CN CN202110883588.XA patent/CN113633832A/en active Pending
Patent Citations (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050208100A1 (en) * | 2004-03-19 | 2005-09-22 | Jan Weber | Medical articles having regions with polyelectrolyte multilayer coatings for regulating drug release |
| US20050266038A1 (en) * | 2004-05-27 | 2005-12-01 | Thierry Glauser | Antifouling heparin coatings |
| CN1736504A (en) * | 2005-07-25 | 2006-02-22 | 南通大学 | Nanometer compound antibacterial rubber urinary catheter and manufacturing method thereof |
| CN101812265A (en) * | 2009-02-24 | 2010-08-25 | 赛诺医疗科学技术有限公司 | Hydrophilic coat solution applied to surface of medicinal instrument and preparation method thereof |
| US20140271774A1 (en) * | 2013-03-14 | 2014-09-18 | W. L, Gore & Associates, Inc, | Coating For A Surface |
| CN103301551A (en) * | 2013-06-09 | 2013-09-18 | 广州维力医疗器械股份有限公司 | Wetting component for hydrophilic urinary catheter |
| CN103948971A (en) * | 2014-03-20 | 2014-07-30 | 北京迪玛克医药科技有限公司 | Intervention catheter surface treatment method and intervention catheter |
| CN105983138A (en) * | 2015-02-11 | 2016-10-05 | 北京迪玛克医药科技有限公司 | Hydrophilic lubricating polyurethane medical interventional catheter and manufacturing method thereof |
| CN105963798A (en) * | 2015-10-15 | 2016-09-28 | 淮海工学院 | Water-based lubricant, preparation method and application thereof |
| CN105597217A (en) * | 2016-02-29 | 2016-05-25 | 浙江曙光科技有限公司 | PVC ultra-smooth hydrophilic catheter and preparation method thereof |
| CN110373069A (en) * | 2018-04-12 | 2019-10-25 | 中国科学院化学研究所 | A kind of hydrogel coating and the preparation method and application thereof |
| CN109045367A (en) * | 2018-07-13 | 2018-12-21 | 北京化工大学 | A kind of preparation method of hydrophilic coating and products thereof on medical catheter seal wire surface |
Non-Patent Citations (2)
| Title |
|---|
| 张光华编: "《水处理化学品制备与应用指南》", 31 October 2003 * |
| 张长清等主编: "《建筑装饰材料》", 30 December 2019, 华中科技大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8906403B2 (en) | Biomaterials carrying cyclodextrins having improved absorption properties and used for the progressive and delayed release of therapeutic molecules | |
| US4539234A (en) | Urethral catheter capable of preventing urinary tract infection and process for producing the same | |
| EP1363684B1 (en) | Method of making anti-microbial polymeric surfaces | |
| JPH0687968A (en) | Method for grafting previously formed hydrophilic polymer onto base hydrophobic polymer, and coating composition therefor | |
| AU2002235694A1 (en) | Method of making anti-microbial polymeric surfaces | |
| Zhang et al. | A conformally adapted all-in-one hydrogel coating: towards robust hemocompatibility and bactericidal activity | |
| JP2003529630A (en) | Polymer composition containing silver salt colloid | |
| CN112843342A (en) | Material with biological anti-fouling function, preparation method and application thereof | |
| WO2013180940A1 (en) | Hydrophilic and non-thrombogenic polymer for coating of medical devices | |
| JP2012510301A (en) | Biodegradable blend for temporary skeleton of blood vessel wall (auxiliary material) | |
| CN112870437A (en) | Functional material with anticoagulation, anti-hyperplasia and endothelialization promotion functions, and preparation method and application thereof | |
| Park et al. | Polysaccharide-derivative coated intravascular catheters with superior multifunctional performance via simple and biocompatible method | |
| CN114246992B (en) | Degradable intravascular stent with slow-release drug coating and preparation method thereof | |
| CN113633832A (en) | Method for manufacturing ureteral stent anti-crusting coating based on anionic resin | |
| CN110054984A (en) | A kind of preparation method of the covalent cross-linking self-healing antimicrobial coating of stable structure | |
| US20160022882A1 (en) | Medical implements and medical implement production methods | |
| CN111467571A (en) | Super-hydrophilic multifunctional cardiovascular coating material and preparation method thereof | |
| CN114159627B (en) | Composite hydrogel coating for monitoring and treating urinary tract infection and preparation method and application thereof | |
| EP3562513B1 (en) | Nanoreservoirs | |
| CN114432506A (en) | Zwitterion functionalized biological material, and preparation method and application thereof | |
| CN113171498A (en) | SDS-LA/PLGA/APTES antibacterial coating | |
| CN114618024B (en) | Endothelial function bionic material, preparation method and application thereof | |
| JPH03223377A (en) | Functional group-containing substrate, preparation of the same, and medical material and equipment using the substrate | |
| Butruk et al. | Polyvinylpyrrolidone-based coatings for polyurethanes–the effect of reagent concentration on their chosen physical properties | |
| JPH10234846A (en) | Anti-thrombus material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211112 |